Mycenax Biotech Inc. (TPEX:4726)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
37.50
+0.20 (0.54%)
Apr 2, 2025, 1:30 PM CST

Mycenax Biotech Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
7,7638,9677,3507,6995,8114,129
Upgrade
Market Cap Growth
22.00%22.00%-4.53%32.48%40.74%38.50%
Upgrade
Enterprise Value
8,3699,4817,2818,3535,9983,966
Upgrade
Last Close Price
37.5043.4035.7037.5037.9032.20
Upgrade
PE Ratio
-----133.43
Upgrade
PS Ratio
11.3013.1111.2610.517.516.21
Upgrade
PB Ratio
3.844.433.002.483.053.41
Upgrade
P/TBV Ratio
4.514.513.062.523.143.59
Upgrade
P/OCF Ratio
----23.71
Upgrade
EV/Sales Ratio
12.2413.8611.1611.417.755.96
Upgrade
EV/EBITDA Ratio
---135.3226.30
Upgrade
EV/EBIT Ratio
----112.05
Upgrade
Debt / Equity Ratio
0.440.440.300.310.390.16
Upgrade
Debt / EBITDA Ratio
----9.961.15
Upgrade
Asset Turnover
0.190.190.160.190.320.42
Upgrade
Inventory Turnover
10.4410.445.734.034.936.79
Upgrade
Quick Ratio
0.640.640.972.241.151.10
Upgrade
Current Ratio
1.111.111.463.031.661.36
Upgrade
Return on Equity (ROE)
-20.90%-20.90%-24.59%-18.10%-5.76%2.67%
Upgrade
Return on Assets (ROA)
-8.08%-8.08%-9.15%-7.33%-2.18%1.40%
Upgrade
Return on Capital (ROIC)
-9.49%-9.49%-10.40%-8.29%-2.63%1.73%
Upgrade
Return on Capital Employed (ROCE)
-----2.70%
Upgrade
Earnings Yield
-6.02%-5.21%-9.29%-5.89%-1.55%0.75%
Upgrade
FCF Yield
-6.73%-5.82%-5.81%-10.09%-21.41%-2.08%
Upgrade
Buyback Yield / Dilution
-0.23%-0.23%-24.31%-11.35%-15.36%-2.37%
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.